Albumin, Bilirubin, Cirrhosis and Ethics: The ABCs of Liver Failure

Activity Summary

In the United States, roughly 2,000 people develop acute liver failure annually; 4.5 million people are living with chronic liver disease. This intermediate session offers an overview of the pathophysiology and management of the acute and critically ill patient with acute liver failure, decompensated cirrhosis and acute-on-chronic liver failure. Moral issues and distress patients, families and caregivers encounter when caring for patients with liver failure in the critical care environment are explored. Polling technology is used to engage exam studies. Pharmacology content = 60%

Objectives

Analyze the pathophysiology of acute, acute-on-chronic, and chronic liver diseases.
Assess and manage patients with acute, chronic and acute-on-chronic liver disease, including medications and extracorporeal liver support.
Describe the ethical concerns of caring for patients with acute and chronic liver disease.

Continuing Education Disclosure Statement

Criteria for Awarding Contact Hours

Learners must complete the entire activity and the associated evaluation AND read Implicit Bias impacts patient outcomes. No partial credit will be awarded.

Accreditation

American Association of Critical-Care Nurses is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
Provider approved by the California Board of Registered Nursing, Provider number CEP 1036, for {contactHours} contact hours.

Disclosures

The Nurse Planner has determined that no individuals with the ability to control content of this activity have relevant relationships with ineligible companies.

Activities with pharmacotherapeutic credit are to assist the APRN in fulfilling their education requirements for licensure and certification renewals.

Refund Policy

Continuing Education Activities are nonrefundable.